| Sandoz Pharmaceuticals AG - Estradot 75, Transdermales Pflaster |
| 55976 | | 03 | | Estradot 75 | | Transdermales Pflaster | | G03CA03 | | Estradiol | | 25.06.2002 | | |
|
| Composition |
| estradiolum 1.17 mg ut estradiolum hemihydricum, dipropylenglycolum, excipiens ad praeparationem pro 7.5 cm² cum liberatione 75 µg/24 h. |
| Packungsbestandteile |
| Transdermal patch | | | | | | | | Active Agent | Dose |
|---|
| Estradiol | 1.17 mg |
| | BAG: Active Agent | Dose |
|---|
| Estradiol | 1.17 mg |
| | | | Inactive agents |
|---|
| Dipropylenglycol |
| |
|
|
